BYSI
BeyondSpring (BYSI)
$87
About BeyondSpring (BYSI)
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.
Details
Daily high
$1.98
Daily low
$1.79
Price at open
$1.84
52 Week High
$3.44
52 Week Low
$0.98
Market cap
78.1M
Dividend yield
0.00%
Volume
135,067
Avg. volume
694,827
P/E ratio
-4.77
BeyondSpring News
Details
Daily high
$1.98
Daily low
$1.79
Price at open
$1.84
52 Week High
$3.44
52 Week Low
$0.98
Market cap
78.1M
Dividend yield
0.00%
Volume
135,067
Avg. volume
694,827
P/E ratio
-4.77